Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Wearable devices offer huge potential to collect rich sources of data to provide insights into the effects of treatment interventions. Despite this, at the time of writing this report, limited regulatory guidance on the use of wearables in clinical trial programs has been published. OBJECTIVES: To present recommendations from the Critical Path Institute's Electronic Patient-Reported Outcome Consortium regarding the selection and evaluation of wearable devices and their measurements for use in regulatory trials and to support labeling claims. METHODS: The evaluation group was composed of Critical Path Institute's clinical outcome assessment (COA) scientists and COA specialists from pharmaceutical trial eCOA solution providers, including COA development and validation specialists. The resulting recommendations were drawn from a broad range of backgrounds, perspectives, and expertise that enriched the development of this report. Recommendations were developed through analysis of existing regulatory guidance relating to COA development and use in clinical trials, medical device certification/clearance regulations, literature-reported best practice, and practical experience of wearable technology application in clinical trials. RESULTS: We identify the essential properties of fit-for-purpose wearables and propose evidence needed to support their use. In addition, we overview the activities required to establish clinical endpoints derived from wearables data. CONCLUSIONS: Using this framework, we believe there is enough current understanding to promote the appropriate use of wearables in study protocols. We hope this will provide a basis for discussion among clinical trial stakeholders and catalyze the development of more robust regulatory guidance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of the GENEA Accelerometer
ESLIGER, D. W., ROWLANDS, A. V., HURST, T. L., CATT, M., MURRAY, P., & ESTON, R. G. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31820513be · Cited by 625
The minimal important difference in physical activity in patients with COPD
Demeyer, H., Burtin, C., Hornikx, M., Camillo, C. A., Van Remoortel, H., Langer, D., Janssens, W., & Troosters, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154587 · Cited by 282 · cited 2×
“Examples of estimation of meaningful change for endpoints derived from wearables include minimally clinically important difference estimation for the total daily steps measured using an accelerometer for patients with chronic obstructive pulmonary disease [26] and multiple sclerosis [27].”
BackgroundMethodFeasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
Belknap, R., Weis, S., Brookens, A., Au-Yeung, K. Y., Moon, G., DiCarlo, L., & Reves, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053373 · Cited by 160
Cited by
Review of Wearable Devices and Data Collection Considerations for Connected Health
Vijayan, V., Connolly, J. P., Condell, J., McKelvey, N., & Gardiner, P. (2021) · Sensors · doi:10.3390/s21165589 · Cited by 435
“Wearable applications must be easy to use and easily integrated into consumers’ daily lives if they are to be used for ongoing monitoring without causing disruption [119].”
BackgroundDeveloping and adopting safe and effective digital biomarkers to improve patient outcomes
Coravos, A., Khozin, S., & Mandl, K. D. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0090-4 · Cited by 361
The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review
Beauchamp, U. L., Pappot, H., & Holländer-Mieritz, C. (2020) · JMIR mHealth and uHealth · doi:10.2196/22006 · Cited by 110
Taylor, K. I., Staunton, H., Lipsmeier, F., Nobbs, D., & Lindemann, M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0305-8 · Cited by 85
Noninvasive Continuous Monitoring of Vital Signs With Wearables: Fit for Medical Use?
Jacobsen, M., Dembek, T. A., Kobbe, G., Gaidzik, P. W., & Heinemann, L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820904947 · Cited by 49
Metadata
- Authors
- Byrom, B., Watson, C., Doll, H., Coons, S. J., Eremenco, S., Ballinger, R., Mc Carthy, M., Crescioni, M., O’Donohoe, P., & Howry, C.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 21
- Issue
- 6
- Pages
- 631-639
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2767543826
- Cited by
- 79
- References
- 3
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium. https://app.cochat.ai/papers/10.1016/j.jval.2017.09.012
- The paper
- Byrom, B., Watson, C., Doll, H., Coons, S. J., Eremenco, S., Ballinger, R., Mc Carthy, M., Crescioni, M., O’Donohoe, P., & Howry, C. (2018). Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium. Value in Health. https://doi.org/10.1016/j.jval.2017.09.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.